Schrodinger Inc
(STU:43Z)
€
13.27
+0.095 (+0.72%)
Market Cap: 984.53 Mil
Enterprise Value: 728.12 Mil
PE Ratio: 0
PB Ratio: 3.60
GF Score: 56/100 Schrodinger Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 06:05PM GMT
Unidentified Participant
Next up is Schrodinger. Schrodinger is a tech-enabled drug development company, I think, known for computational chemistry and a unique or an aspect of your business that I think is of interest and will cover is also have a portfolio of proprietary work, through partnerships or otherwise.
But I'm happy to be joined by Ramy Farid, CEO and Richie Jain, CFO. Thank you both for taking the time.
Ramy Farid
Schrodinger Inc - President, Chief Executive Officer, Director
Yeah, thanks for having us.
Richie Jain
Schrodinger Inc - Executive Vice President, Chief Financial Officer, Treasurer
Thank you. It's our first time attending this conference. So thank you for the invite.
Ramy Farid
Schrodinger Inc - President, Chief Executive Officer, Director
Great conference so far. Great.
Questions & Answers
Unidentified Participant
Well, glad to hear it. I wanted to start with just talking about the end market. Maybe
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot